Literature DB >> 6721610

Longitudinal pancreaticojejunostomy in chronic relapsing pancreatitis with onset in childhood.

H W Scott, W W Neblett, J A O'Neill, J L Sawyers, G S Avant, V A Starnes.   

Abstract

Despite the rarity of chronic relapsing pancreatitis in children, in the last 15 years at Vanderbilt University Medical Center and its Children's Hospital we have used longitudinal pancreaticojejunostomy in treatment of eight patients whose symptoms began in childhood. Duration of symptoms ranged from 2 to 36 years. Seven of the eight patients had hereditary pancreatitis. Recurrent epigastric pain was characteristic and serum amylase was elevated in all patients on admission or shortly thereafter. Demonstration of an obstructed dilated pancreatic duct in all and stones in seven of eight patients by operative pancreatography in three early patients and by endoscopic retrograde cholangiopancreatography (ERCP) in five others established the therapeutic problem and facilitated treatment by removal of stones and longitudinal pancreaticojejunostomy. Results were uniformly excellent, both in the early postoperative period and in long-range follow-ups. Early diagnosis and early surgical drainage of the obstructed pancreatic duct by longitudinal pancreaticojejunostomy are desirable objectives in chronic relapsing pancreatitis with onset in childhood.

Entities:  

Mesh:

Year:  1984        PMID: 6721610      PMCID: PMC1353504          DOI: 10.1097/00000658-198405000-00017

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  21 in total

1.  PANCREATITIS IN CHILDHOOD: EXPERIENCE WITH 15 CASES.

Authors:  W H HENDREN; J M GREEP; A S PATTON
Journal:  Arch Dis Child       Date:  1965-04       Impact factor: 3.791

2.  The role of incomplete pancreatic duct obstruction in the etiology of pancreatitis.

Authors:  R E HERMANN; J H DAVIS
Journal:  Surgery       Date:  1960-08       Impact factor: 3.982

3.  Stenosis of the sphincter of Oddi.

Authors:  R B CATTELL; B P COLCOCK; J L POLLACK
Journal:  N Engl J Med       Date:  1957-03-07       Impact factor: 91.245

4.  Caudal pancreatico-jejunostomy for chronic relapsing pancreatitis.

Authors:  M K DUVAL
Journal:  Ann Surg       Date:  1954-12       Impact factor: 12.969

5.  Splenic studies. I. Susceptibility to infection after splenectomy performed in infancy.

Authors:  H KING; H B SHUMACKER
Journal:  Ann Surg       Date:  1952-08       Impact factor: 12.969

6.  Surgical treatment of pancreatitis: review of a series.

Authors:  M A Adson
Journal:  Mayo Clin Proc       Date:  1979-07       Impact factor: 7.616

7.  Hereditary pancreatitis. Review and presentation of an additional kindred.

Authors:  M F Appel
Journal:  Arch Surg       Date:  1974-01

8.  Chronic relapsing pancreatitis in childhood: case report and review of the literature.

Authors:  R H Dean; H W Scott; D H Law
Journal:  Ann Surg       Date:  1971-03       Impact factor: 12.969

9.  Chronic fibrosing pancreatitis in childhood: a cause of recurrent abdominal pain.

Authors:  T E Williams; N J Sherman; H W Clatworthy
Journal:  Pediatrics       Date:  1967-12       Impact factor: 7.124

10.  Recurrent acute pancreatitis in patients with cystic fibrosis with normal pancreatic enzymes.

Authors:  H Shwachman; E Lebenthal; K T Khaw
Journal:  Pediatrics       Date:  1975-01       Impact factor: 7.124

View more
  3 in total

1.  The impact of surgical strategies on outcomes for pediatric chronic pancreatitis.

Authors:  Maria G Sacco Casamassima; Seth D Goldstein; Jingyan Yang; Colin D Gause; Fizan Abdullah; Avner Meoded; Martin A Makary; Paul M Colombani
Journal:  Pediatr Surg Int       Date:  2016-11-04       Impact factor: 1.827

2.  Management of chronic relapsing pancreatitis in adolescents.

Authors:  J E Trapnell
Journal:  World J Surg       Date:  1990 Jan-Feb       Impact factor: 3.352

3.  Denervated splenopancreatic flap for chronic pancreatitis.

Authors:  G T Shires; W D Warren; W J Millikan; J M Henderson; T Hersh
Journal:  Ann Surg       Date:  1986-05       Impact factor: 12.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.